Your browser doesn't support javascript.
loading
Analysis of clinical trials of new drugs in China as of 2019.
Lin, Longfei; Chen, Yiren; Yan, Lei; Liu, Yuling; Ni, Jian; Yang, Hongjun; Li, Hui.
Afiliação
  • Lin L; Institute Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
  • Chen Y; Iowa State University, Ames, IA, USA.
  • Yan L; Fengtai District Community Health Center, Beijing, China.
  • Liu Y; Institute Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
  • Ni J; School of Chinese Material Medica, Beijing University of Chinese Medicine, Beijing, China. Electronic address: njtcm@263.net.
  • Yang H; Institute Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: hjyang@icmm.ac.cn.
  • Li H; Institute Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: lihuizys@126.com.
Drug Discov Today ; 25(12): 2080-2088, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33017690
ABSTRACT
The research and development (R&D) of new drugs indicates scientific progress and economic development. However, little is known regarding ongoing or recent clinical trials in China. We analyzed data from clinical trials published before December 31, 2019, and found that the annual registration numbers are increasing annually in the country. Based on clinical indications, most tested drugs target cancers, nervous system, infections, and the cardiovascular system. Furthermore, clinical trials are mostly concentrated in Beijing, Shanghai, and Jiangsu, and conducted by large pharmaceutical companies, with multiple trials for several generic drugs. Going forward, it will be necessary to promote R&D in China of clinically relevant innovative drugs, drug delivery systems, and novel traditional Chinese medicine (TCM) and biological products, as well as to have a balanced distribution of clinical trials to sustainably meet public health needs.
Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Idioma: Inglês Revista: Drug Discov Today Assunto da revista: Farmacologia / Terapia por Medicamentos Ano de publicação: 2020 Tipo de documento: Artigo País de afiliação: China

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Idioma: Inglês Revista: Drug Discov Today Assunto da revista: Farmacologia / Terapia por Medicamentos Ano de publicação: 2020 Tipo de documento: Artigo País de afiliação: China
...